A Study of Barzolvolimab in Patients With Atopic Dermatitis

Clinical trial NCT06727552 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06727552
Sponsor: Celldex Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2024-12-18
Primary completion: 2026-05-06
Enrollment: 131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.